Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 668
Selected: 0
NCT IDTitle
NCT01299454A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
NCT01556646Effect of Tolvaptan on Cognitive Function in Cirrhosis
NCT01660256Confirmatory Study of OPC-12759 Ophthalmic Solution
NCT01475370Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)
NCT05279313A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD).
NCT02349919Effect of Oral Procaterol on Postinfectious Persistent Cough
NCT02251275Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT03605849A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
NCT00232687A Switch Study of BMS-337039 in Schizophrenic Out-patients
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT01111539Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT05542264A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
NCT01424566A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
NCT00202007Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
NCT02545101An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH
NCT00043758Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT03198078Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
NCT00043771Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT00036101Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
NCT02174822A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects
NCT02994394A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
NCT00110461Aripiprazole in Children and Adolescents With Bipolar I Disorder
NCT03095066Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
NCT00097266Study of Aripiprazole in Patients With Acute Bipolar Mania
NCT06674291Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
NCT06928142A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
NCT00283179Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
NCT05667623To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
NCT03643159A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
NCT03141060Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB
NCT01228682Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
NCT01723059Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
NCT01214421Tolvaptan Extension Study in Participants With ADPKD
NCT00576706PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
NCT01026584Efficacy and Safety of Aripiprazole in First Episode Psychosis
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT00080327Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
NCT00550459Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
NCT01565018Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects
NCT01940159A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT01027013Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
NCT01444885Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
NCT01632137Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
NCT07105124Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject
NCT00996788Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
NCT03287869A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
NCT01810783Brexpiprazole in Patients With Schizophrenia
NCT01944969Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
NCT01739829Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus